当前位置:首页 - 行情中心 - 鱼跃医疗(002223) - 财务分析 - 现金流量表

鱼跃医疗

(002223)

  

流通市值:274.02亿  总市值:291.52亿
流通股本:9.42亿   总股本:10.02亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,337,089,006.098,446,976,414.86,608,481,380.284,377,341,386.03
  收到的税费返还24,628,296.95125,258,728.7380,186,352.0857,174,723.33
  收到其他与经营活动有关的现金144,956,920.22436,519,015.28457,714,416.57393,223,868.88
  经营活动现金流入小计2,506,674,223.269,008,754,158.817,146,382,148.934,827,739,978.24
  购买商品、接受劳务支付的现金879,023,035.713,592,983,429.872,542,105,028.621,507,507,856.15
  支付给职工以及为职工支付的现金455,517,076.581,429,181,740.051,047,524,577.83734,821,553.48
  支付的各项税费112,798,055.52733,592,109.83750,736,983.24551,976,450.39
  支付其他与经营活动有关的现金462,224,618.981,750,075,163.271,302,514,887.79866,573,440.88
  经营活动现金流出小计1,909,562,786.797,505,832,443.025,642,881,477.483,660,879,300.9
  经营活动产生的现金流量净额597,111,436.471,502,921,715.791,503,500,671.451,166,860,677.34
二、投资活动产生的现金流量:
  收回投资收到的现金3,448,275.839,273,034.369,380,409.368,534,089.95
  取得投资收益收到的现金4,827,586.1756,211,37356,113,760.8133,774,434.38
  处置固定资产、无形资产和其他长期资产收回的现金净额4,30075,932,363.3375,254,535.975,419,373.48
  投资活动现金流入小计8,280,162141,416,770.69140,748,706.07117,727,897.81
  购建固定资产、无形资产和其他长期资产支付的现金27,790,853.99128,981,496.52102,287,711.5960,684,869.58
  投资支付的现金-260,912,035.33270,935,060.22197,481,592.01
  支付其他与投资活动有关的现金178,832,8006,403,545,608.02--
  投资活动现金流出小计206,623,653.996,793,439,139.87373,222,771.81258,166,461.59
  投资活动产生的现金流量净额-198,343,491.99-6,652,022,369.18-232,474,065.74-140,438,563.78
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金5,336,538.8-9,701,657.19,701,657.1
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计5,336,538.8-9,701,657.19,701,657.1
  偿还债务支付的现金-20,866,190.21--
  分配股利、利润或偿付利息支付的现金-799,010,395.35399,742,211.64399,742,211.64
  支付其他与筹资活动有关的现金7,367,804.141,941,120.4312,681,001.357,201,657.1
  筹资活动现金流出小计7,367,804.14821,817,705.99412,423,212.99406,943,868.74
  筹资活动产生的现金流量净额-2,031,265.34-821,817,705.99-402,721,555.89-397,242,211.64
四、汇率变动对现金及现金等价物的影响-34,154,362.67-51,975,920.09-21,220,102.32-12,673,315.72
五、现金及现金等价物净增加额362,582,316.47-6,022,894,279.47847,084,947.5616,506,586.2
  加:期初现金及现金等价物余额573,104,129.456,595,998,408.926,595,998,408.926,595,998,408.92
  期末现金及现金等价物余额935,686,445.92573,104,129.457,443,083,356.427,212,504,995.12
补充资料:
  净利润-1,484,136,250.87-1,199,667,055.45
  资产减值准备-33,472,241.75-36,206,550.48
  固定资产和投资性房地产折旧-194,087,512.34-94,490,375.5
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-194,087,512.34-94,490,375.5
  无形资产摊销-45,093,871.94-12,524,793.93
  长期待摊费用摊销-53,047,910.71-23,225,165.45
  处置固定资产、无形资产和其他长期资产的损失--1,281,395.38--1,249,796.19
  固定资产报废损失-1,300,431.57-195,402.15
  财务费用--32,529,930.72-13,202,827.65
  投资损失--34,149,903.34--32,692,343.07
  递延所得税--1,653,839.83--5,200,031.3
  其中:递延所得税资产减少-3,157,628.21--351,758.85
    递延所得税负债增加--4,811,468.04--4,848,272.45
  存货的减少--56,783,515.72-262,423,239.04
  经营性应收项目的减少-157,281,765.51--581,163,253.85
  经营性应付项目的增加--358,667,405.04-121,796,708.25
  其他--6,607,260.62-10,148,539.37
  现金的期末余额-573,104,129.45-7,212,504,995.12
  减:现金的期初余额-6,595,998,408.92-6,595,998,408.92
  现金及现金等价物的净增加额--6,022,894,279.47-616,506,586.2
公告日期2026-04-252026-04-252025-10-252025-08-23
审计意见(境内)标准无保留意见
TOP↑